The Drug Science Podcast

Professor Allan Young is a psychopharmacologist and the Director of the Centre for Affective Disorders in the Department of Psychological Medicine in the Institute of Psychiatry, Psychology and Neuroscience at King’s College London. Prof Young is the clinical academic lead in the Psychological Medicine and Integrated Care Clinical Academic Group in the South London and Maudsley NHS Trust where he is also a Consultant Psychiatrist and the head of the National Affective Disorders Tertiary Clinic.  

Professor Young’s research interests focus on the cause and treatments for severe psychiatric illnesses, particularly mood disorders like depression. He has received research grant funding from the UK Medical Research Council, the Wellcome Trust, and numerous other respected funding agencies worldwide. He has published over 400 peer-reviewed publications and a number of books about psychopharmacology and affective disorders. According to the 2014 Thomson Reuters Highly Cited Researcher list, Professor Young was recently ranked as one of the world's leading scientific minds in the field of Psychiatry and Psychology. 

Depression

Bipolar disorder

Major depressive episode

Anhedonia

ICD-10

DSM-5

Atypical depression

Immuno-metabolic depression

SSRI

Rapid cycling bipolar disorder

Tricyclic antidepressants

Monoamine oxidase inhibitors (MAOIs)

Dopamine receptor D2

Cognitive Remediation Therapy

Institute of Psychiatry, Psychology & Neuroscience

CBT

Ketamine

Esketamine: Ketamine nasal spray 

Bioavailability

Psilocybin: From Serendipity to Credibility?

COMPASS Pathways

★ Support this podcast ★

Professor Allan Young is a psychopharmacologist and the Director of the Centre for Affective Disorders in the Department of Psychological Medicine in the Institute of Psychiatry, Psychology and Neuroscience at King’s College London. Prof Young is the clinical academic lead in the Psychological Medicine and Integrated Care Clinical Academic Group in the South London and Maudsley NHS Trust where he is also a Consultant Psychiatrist and the head of the National Affective Disorders Tertiary Clinic.  

Professor Young’s research interests focus on the cause and treatments for severe psychiatric illnesses, particularly mood disorders like depression. He has received research grant funding from the UK Medical Research Council, the Wellcome Trust, and numerous other respected funding agencies worldwide. He has published over 400 peer-reviewed publications and a number of books about psychopharmacology and affective disorders. According to the 2014 Thomson Reuters Highly Cited Researcher list, Professor Young was recently ranked as one of the world's leading scientific minds in the field of Psychiatry and Psychology. 

Depression

Bipolar disorder

Major depressive episode

Anhedonia

ICD-10

DSM-5

Atypical depression

Immuno-metabolic depression

SSRI

Rapid cycling bipolar disorder

Tricyclic antidepressants

Monoamine oxidase inhibitors (MAOIs)

Dopamine receptor D2

Cognitive Remediation Therapy

Institute of Psychiatry, Psychology & Neuroscience

CBT

Ketamine

Esketamine: Ketamine nasal spray 

Bioavailability

Psilocybin: From Serendipity to Credibility?

COMPASS Pathways

★ Support this podcast ★

Professor Allan Young is a psychopharmacologist and the Director of the Centre for Affective Disorders in the Department of Psychological Medicine in the Institute of Psychiatry, Psychology and Neuroscience at King’s College London. Prof Young is the clinical academic lead in the Psychological Medicine and Integrated Care Clinical Academic Group in the South London and Maudsley NHS Trust where he is also a Consultant Psychiatrist and the head of the National Affective Disorders Tertiary Clinic.  

Professor Young’s research interests focus on the cause and treatments for severe psychiatric illnesses, particularly mood disorders like depression. He has received research grant funding from the UK Medical Research Council, the Wellcome Trust, and numerous other respected funding agencies worldwide. He has published over 400 peer-reviewed publications and a number of books about psychopharmacology and affective disorders. According to the 2014 Thomson Reuters Highly Cited Researcher list, Professor Young was recently ranked as one of the world's leading scientific minds in the field of Psychiatry and Psychology. 

Depression

Bipolar disorder

Major depressive episode

Anhedonia

ICD-10

DSM-5

Atypical depression

Immuno-metabolic depression

SSRI

Rapid cycling bipolar disorder

Tricyclic antidepressants

Monoamine oxidase inhibitors (MAOIs)

Dopamine receptor D2

Cognitive Remediation Therapy

Institute of Psychiatry, Psychology & Neuroscience

CBT

Ketamine

Esketamine: Ketamine nasal spray 

Bioavailability

Psilocybin: From Serendipity to Credibility?

COMPASS Pathways

★ Support this podcast ★

Professor Allan Young is a psychopharmacologist and the Director of the Centre for Affective Disorders in the Department of Psychological Medicine in the Institute of Psychiatry, Psychology and Neuroscience at King’s College London. Prof Young is the clinical academic lead in the Psychological Medicine and Integrated Care Clinical Academic Group in the South London and Maudsley NHS Trust where he is also a Consultant Psychiatrist and the head of the National Affective Disorders Tertiary Clinic.  

Professor Young’s research interests focus on the cause and treatments for severe psychiatric illnesses, particularly mood disorders like depression. He has received research grant funding from the UK Medical Research Council, the Wellcome Trust, and numerous other respected funding agencies worldwide. He has published over 400 peer-reviewed publications and a number of books about psychopharmacology and affective disorders. According to the 2014 Thomson Reuters Highly Cited Researcher list, Professor Young was recently ranked as one of the world's leading scientific minds in the field of Psychiatry and Psychology. 

Depression

Bipolar disorder

Major depressive episode

Anhedonia

ICD-10

DSM-5

Atypical depression

Immuno-metabolic depression

SSRI

Rapid cycling bipolar disorder

Tricyclic antidepressants

Monoamine oxidase inhibitors (MAOIs)

Dopamine receptor D2

Cognitive Remediation Therapy

Institute of Psychiatry, Psychology & Neuroscience

CBT

Ketamine

Esketamine: Ketamine nasal spray 

Bioavailability

Psilocybin: From Serendipity to Credibility?

COMPASS Pathways

★ Support this podcast ★

Professor Allan Young is a psychopharmacologist and the Director of the Centre for Affective Disorders in the Department of Psychological Medicine in the Institute of Psychiatry, Psychology and Neuroscience at King’s College London. Prof Young is the clinical academic lead in the Psychological Medicine and Integrated Care Clinical Academic Group in the South London and Maudsley NHS Trust where he is also a Consultant Psychiatrist and the head of the National Affective Disorders Tertiary Clinic.  

Professor Young’s research interests focus on the cause and treatments for severe psychiatric illnesses, particularly mood disorders like depression. He has received research grant funding from the UK Medical Research Council, the Wellcome Trust, and numerous other respected funding agencies worldwide. He has published over 400 peer-reviewed publications and a number of books about psychopharmacology and affective disorders. According to the 2014 Thomson Reuters Highly Cited Researcher list, Professor Young was recently ranked as one of the world's leading scientific minds in the field of Psychiatry and Psychology. 

Depression

Bipolar disorder

Major depressive episode

Anhedonia

ICD-10

DSM-5

Atypical depression

Immuno-metabolic depression

SSRI

Rapid cycling bipolar disorder

Tricyclic antidepressants

Monoamine oxidase inhibitors (MAOIs)

Dopamine receptor D2

Cognitive Remediation Therapy

Institute of Psychiatry, Psychology & Neuroscience

CBT

Ketamine

Esketamine: Ketamine nasal spray 

Bioavailability

Psilocybin: From Serendipity to Credibility?

COMPASS Pathways

★ Support this podcast ★

Professor Allan Young is a psychopharmacologist and the Director of the Centre for Affective Disorders in the Department of Psychological Medicine in the Institute of Psychiatry, Psychology and Neuroscience at King’s College London. Prof Young is the clinical academic lead in the Psychological Medicine and Integrated Care Clinical Academic Group in the South London and Maudsley NHS Trust where he is also a Consultant Psychiatrist and the head of the National Affective Disorders Tertiary Clinic.  

Professor Young’s research interests focus on the cause and treatments for severe psychiatric illnesses, particularly mood disorders like depression. He has received research grant funding from the UK Medical Research Council, the Wellcome Trust, and numerous other respected funding agencies worldwide. He has published over 400 peer-reviewed publications and a number of books about psychopharmacology and affective disorders. According to the 2014 Thomson Reuters Highly Cited Researcher list, Professor Young was recently ranked as one of the world's leading scientific minds in the field of Psychiatry and Psychology. 

Depression

Bipolar disorder

Major depressive episode

Anhedonia

ICD-10

DSM-5

Atypical depression

Immuno-metabolic depression

SSRI

Rapid cycling bipolar disorder

Tricyclic antidepressants

Monoamine oxidase inhibitors (MAOIs)

Dopamine receptor D2

Cognitive Remediation Therapy

Institute of Psychiatry, Psychology & Neuroscience

CBT

Ketamine

Esketamine: Ketamine nasal spray 

Bioavailability

Psilocybin: From Serendipity to Credibility?

COMPASS Pathways

★ Support this podcast ★

Professor Allan Young is a psychopharmacologist and the Director of the Centre for Affective Disorders in the Department of Psychological Medicine in the Institute of Psychiatry, Psychology and Neuroscience at King’s College London. Prof Young is the clinical academic lead in the Psychological Medicine and Integrated Care Clinical Academic Group in the South London and Maudsley NHS Trust where he is also a Consultant Psychiatrist and the head of the National Affective Disorders Tertiary Clinic.  

Professor Young’s research interests focus on the cause and treatments for severe psychiatric illnesses, particularly mood disorders like depression. He has received research grant funding from the UK Medical Research Council, the Wellcome Trust, and numerous other respected funding agencies worldwide. He has published over 400 peer-reviewed publications and a number of books about psychopharmacology and affective disorders. According to the 2014 Thomson Reuters Highly Cited Researcher list, Professor Young was recently ranked as one of the world's leading scientific minds in the field of Psychiatry and Psychology. 

Depression

Bipolar disorder

Major depressive episode

Anhedonia

ICD-10

DSM-5

Atypical depression

Immuno-metabolic depression

SSRI

Rapid cycling bipolar disorder

Tricyclic antidepressants

Monoamine oxidase inhibitors (MAOIs)

Dopamine receptor D2

Cognitive Remediation Therapy

Institute of Psychiatry, Psychology & Neuroscience

CBT

Ketamine

Esketamine: Ketamine nasal spray 

Bioavailability

Psilocybin: From Serendipity to Credibility?

COMPASS Pathways

★ Support this podcast ★

Professor Allan Young is a psychopharmacologist and the Director of the Centre for Affective Disorders in the Department of Psychological Medicine in the Institute of Psychiatry, Psychology and Neuroscience at King’s College London. Prof Young is the clinical academic lead in the Psychological Medicine and Integrated Care Clinical Academic Group in the South London and Maudsley NHS Trust where he is also a Consultant Psychiatrist and the head of the National Affective Disorders Tertiary Clinic.  

Professor Young’s research interests focus on the cause and treatments for severe psychiatric illnesses, particularly mood disorders like depression. He has received research grant funding from the UK Medical Research Council, the Wellcome Trust, and numerous other respected funding agencies worldwide. He has published over 400 peer-reviewed publications and a number of books about psychopharmacology and affective disorders. According to the 2014 Thomson Reuters Highly Cited Researcher list, Professor Young was recently ranked as one of the world's leading scientific minds in the field of Psychiatry and Psychology. 

Depression

Bipolar disorder

Major depressive episode

Anhedonia

ICD-10

DSM-5

Atypical depression

Immuno-metabolic depression

SSRI

Rapid cycling bipolar disorder

Tricyclic antidepressants

Monoamine oxidase inhibitors (MAOIs)

Dopamine receptor D2

Cognitive Remediation Therapy

Institute of Psychiatry, Psychology & Neuroscience

CBT

Ketamine

Esketamine: Ketamine nasal spray 

Bioavailability

Psilocybin: From Serendipity to Credibility?

COMPASS Pathways

★ Support this podcast ★

Professor Allan Young is a psychopharmacologist and the Director of the Centre for Affective Disorders in the Department of Psychological Medicine in the Institute of Psychiatry, Psychology and Neuroscience at King’s College London. Prof Young is the clinical academic lead in the Psychological Medicine and Integrated Care Clinical Academic Group in the South London and Maudsley NHS Trust where he is also a Consultant Psychiatrist and the head of the National Affective Disorders Tertiary Clinic.  

Professor Young’s research interests focus on the cause and treatments for severe psychiatric illnesses, particularly mood disorders like depression. He has received research grant funding from the UK Medical Research Council, the Wellcome Trust, and numerous other respected funding agencies worldwide. He has published over 400 peer-reviewed publications and a number of books about psychopharmacology and affective disorders. According to the 2014 Thomson Reuters Highly Cited Researcher list, Professor Young was recently ranked as one of the world's leading scientific minds in the field of Psychiatry and Psychology. 

Depression

Bipolar disorder

Major depressive episode

Anhedonia

ICD-10

DSM-5

Atypical depression

Immuno-metabolic depression

SSRI

Rapid cycling bipolar disorder

Tricyclic antidepressants

Monoamine oxidase inhibitors (MAOIs)

Dopamine receptor D2

Cognitive Remediation Therapy

Institute of Psychiatry, Psychology & Neuroscience

CBT

Ketamine

Esketamine: Ketamine nasal spray 

Bioavailability

Psilocybin: From Serendipity to Credibility?

COMPASS Pathways

★ Support this podcast ★

Professor Allan Young is a psychopharmacologist and the Director of the Centre for Affective Disorders in the Department of Psychological Medicine in the Institute of Psychiatry, Psychology and Neuroscience at King’s College London. Prof Young is the clinical academic lead in the Psychological Medicine and Integrated Care Clinical Academic Group in the South London and Maudsley NHS Trust where he is also a Consultant Psychiatrist and the head of the National Affective Disorders Tertiary Clinic.  

Professor Young’s research interests focus on the cause and treatments for severe psychiatric illnesses, particularly mood disorders like depression. He has received research grant funding from the UK Medical Research Council, the Wellcome Trust, and numerous other respected funding agencies worldwide. He has published over 400 peer-reviewed publications and a number of books about psychopharmacology and affective disorders. According to the 2014 Thomson Reuters Highly Cited Researcher list, Professor Young was recently ranked as one of the world's leading scientific minds in the field of Psychiatry and Psychology. 

Depression

Bipolar disorder

Major depressive episode

Anhedonia

ICD-10

DSM-5

Atypical depression

Immuno-metabolic depression

SSRI

Rapid cycling bipolar disorder

Tricyclic antidepressants

Monoamine oxidase inhibitors (MAOIs)

Dopamine receptor D2

Cognitive Remediation Therapy

Institute of Psychiatry, Psychology & Neuroscience

CBT

Ketamine

Esketamine: Ketamine nasal spray 

Bioavailability

Psilocybin: From Serendipity to Credibility?

COMPASS Pathways

★ Support this podcast ★

Professor Allan Young is a psychopharmacologist and the Director of the Centre for Affective Disorders in the Department of Psychological Medicine in the Institute of Psychiatry, Psychology and Neuroscience at King’s College London. Prof Young is the clinical academic lead in the Psychological Medicine and Integrated Care Clinical Academic Group in the South London and Maudsley NHS Trust where he is also a Consultant Psychiatrist and the head of the National Affective Disorders Tertiary Clinic.  

Professor Young’s research interests focus on the cause and treatments for severe psychiatric illnesses, particularly mood disorders like depression. He has received research grant funding from the UK Medical Research Council, the Wellcome Trust, and numerous other respected funding agencies worldwide. He has published over 400 peer-reviewed publications and a number of books about psychopharmacology and affective disorders. According to the 2014 Thomson Reuters Highly Cited Researcher list, Professor Young was recently ranked as one of the world's leading scientific minds in the field of Psychiatry and Psychology. 

Depression

Bipolar disorder

Major depressive episode

Anhedonia

ICD-10

DSM-5

Atypical depression

Immuno-metabolic depression

SSRI

Rapid cycling bipolar disorder

Tricyclic antidepressants

Monoamine oxidase inhibitors (MAOIs)

Dopamine receptor D2

Cognitive Remediation Therapy

Institute of Psychiatry, Psychology & Neuroscience

CBT

Ketamine

Esketamine: Ketamine nasal spray 

Bioavailability

Psilocybin: From Serendipity to Credibility?

COMPASS Pathways

★ Support this podcast ★

Professor Allan Young is a psychopharmacologist and the Director of the Centre for Affective Disorders in the Department of Psychological Medicine in the Institute of Psychiatry, Psychology and Neuroscience at King’s College London. Prof Young is the clinical academic lead in the Psychological Medicine and Integrated Care Clinical Academic Group in the South London and Maudsley NHS Trust where he is also a Consultant Psychiatrist and the head of the National Affective Disorders Tertiary Clinic.  

Professor Young’s research interests focus on the cause and treatments for severe psychiatric illnesses, particularly mood disorders like depression. He has received research grant funding from the UK Medical Research Council, the Wellcome Trust, and numerous other respected funding agencies worldwide. He has published over 400 peer-reviewed publications and a number of books about psychopharmacology and affective disorders. According to the 2014 Thomson Reuters Highly Cited Researcher list, Professor Young was recently ranked as one of the world's leading scientific minds in the field of Psychiatry and Psychology. 

Depression

Bipolar disorder

Major depressive episode

Anhedonia

ICD-10

DSM-5

Atypical depression

Immuno-metabolic depression

SSRI

Rapid cycling bipolar disorder

Tricyclic antidepressants

Monoamine oxidase inhibitors (MAOIs)

Dopamine receptor D2

Cognitive Remediation Therapy

Institute of Psychiatry, Psychology & Neuroscience

CBT

Ketamine

Esketamine: Ketamine nasal spray 

Bioavailability

Psilocybin: From Serendipity to Credibility?

COMPASS Pathways

★ Support this podcast ★

Professor Allan Young is a psychopharmacologist and the Director of the Centre for Affective Disorders in the Department of Psychological Medicine in the Institute of Psychiatry, Psychology and Neuroscience at King’s College London. Prof Young is the clinical academic lead in the Psychological Medicine and Integrated Care Clinical Academic Group in the South London and Maudsley NHS Trust where he is also a Consultant Psychiatrist and the head of the National Affective Disorders Tertiary Clinic.  

Professor Young’s research interests focus on the cause and treatments for severe psychiatric illnesses, particularly mood disorders like depression. He has received research grant funding from the UK Medical Research Council, the Wellcome Trust, and numerous other respected funding agencies worldwide. He has published over 400 peer-reviewed publications and a number of books about psychopharmacology and affective disorders. According to the 2014 Thomson Reuters Highly Cited Researcher list, Professor Young was recently ranked as one of the world's leading scientific minds in the field of Psychiatry and Psychology. 

Depression

Bipolar disorder

Major depressive episode

Anhedonia

ICD-10

DSM-5

Atypical depression

Immuno-metabolic depression

SSRI

Rapid cycling bipolar disorder

Tricyclic antidepressants

Monoamine oxidase inhibitors (MAOIs)

Dopamine receptor D2

Cognitive Remediation Therapy

Institute of Psychiatry, Psychology & Neuroscience

CBT

Ketamine

Esketamine: Ketamine nasal spray 

Bioavailability

Psilocybin: From Serendipity to Credibility?

COMPASS Pathways

★ Support this podcast ★

Professor Allan Young is a psychopharmacologist and the Director of the Centre for Affective Disorders in the Department of Psychological Medicine in the Institute of Psychiatry, Psychology and Neuroscience at King’s College London. Prof Young is the clinical academic lead in the Psychological Medicine and Integrated Care Clinical Academic Group in the South London and Maudsley NHS Trust where he is also a Consultant Psychiatrist and the head of the National Affective Disorders Tertiary Clinic.  

Professor Young’s research interests focus on the cause and treatments for severe psychiatric illnesses, particularly mood disorders like depression. He has received research grant funding from the UK Medical Research Council, the Wellcome Trust, and numerous other respected funding agencies worldwide. He has published over 400 peer-reviewed publications and a number of books about psychopharmacology and affective disorders. According to the 2014 Thomson Reuters Highly Cited Researcher list, Professor Young was recently ranked as one of the world's leading scientific minds in the field of Psychiatry and Psychology. 

Depression

Bipolar disorder

Major depressive episode

Anhedonia

ICD-10

DSM-5

Atypical depression

Immuno-metabolic depression

SSRI

Rapid cycling bipolar disorder

Tricyclic antidepressants

Monoamine oxidase inhibitors (MAOIs)

Dopamine receptor D2

Cognitive Remediation Therapy

Institute of Psychiatry, Psychology & Neuroscience

CBT

Ketamine

Esketamine: Ketamine nasal spray 

Bioavailability

Psilocybin: From Serendipity to Credibility?

COMPASS Pathways

★ Support this podcast ★

Professor Allan Young is a psychopharmacologist and the Director of the Centre for Affective Disorders in the Department of Psychological Medicine in the Institute of Psychiatry, Psychology and Neuroscience at King’s College London. Prof Young is the clinical academic lead in the Psychological Medicine and Integrated Care Clinical Academic Group in the South London and Maudsley NHS Trust where he is also a Consultant Psychiatrist and the head of the National Affective Disorders Tertiary Clinic.  

Professor Young’s research interests focus on the cause and treatments for severe psychiatric illnesses, particularly mood disorders like depression. He has received research grant funding from the UK Medical Research Council, the Wellcome Trust, and numerous other respected funding agencies worldwide. He has published over 400 peer-reviewed publications and a number of books about psychopharmacology and affective disorders. According to the 2014 Thomson Reuters Highly Cited Researcher list, Professor Young was recently ranked as one of the world's leading scientific minds in the field of Psychiatry and Psychology. 

Depression

Bipolar disorder

Major depressive episode

Anhedonia

ICD-10

DSM-5

Atypical depression

Immuno-metabolic depression

SSRI

Rapid cycling bipolar disorder

Tricyclic antidepressants

Monoamine oxidase inhibitors (MAOIs)

Dopamine receptor D2

Cognitive Remediation Therapy

Institute of Psychiatry, Psychology & Neuroscience

CBT

Ketamine

Esketamine: Ketamine nasal spray 

Bioavailability

Psilocybin: From Serendipity to Credibility?

COMPASS Pathways

★ Support this podcast ★

Professor Allan Young is a psychopharmacologist and the Director of the Centre for Affective Disorders in the Department of Psychological Medicine in the Institute of Psychiatry, Psychology and Neuroscience at King’s College London. Prof Young is the clinical academic lead in the Psychological Medicine and Integrated Care Clinical Academic Group in the South London and Maudsley NHS Trust where he is also a Consultant Psychiatrist and the head of the National Affective Disorders Tertiary Clinic.  

Professor Young’s research interests focus on the cause and treatments for severe psychiatric illnesses, particularly mood disorders like depression. He has received research grant funding from the UK Medical Research Council, the Wellcome Trust, and numerous other respected funding agencies worldwide. He has published over 400 peer-reviewed publications and a number of books about psychopharmacology and affective disorders. According to the 2014 Thomson Reuters Highly Cited Researcher list, Professor Young was recently ranked as one of the world's leading scientific minds in the field of Psychiatry and Psychology. 

Depression

Bipolar disorder

Major depressive episode

Anhedonia

ICD-10

DSM-5

Atypical depression

Immuno-metabolic depression

SSRI

Rapid cycling bipolar disorder

Tricyclic antidepressants

Monoamine oxidase inhibitors (MAOIs)

Dopamine receptor D2

Cognitive Remediation Therapy

Institute of Psychiatry, Psychology & Neuroscience

CBT

Ketamine

Esketamine: Ketamine nasal spray 

Bioavailability

Psilocybin: From Serendipity to Credibility?

COMPASS Pathways

★ Support this podcast ★

Professor Allan Young is a psychopharmacologist and the Director of the Centre for Affective Disorders in the Department of Psychological Medicine in the Institute of Psychiatry, Psychology and Neuroscience at King’s College London. Prof Young is the clinical academic lead in the Psychological Medicine and Integrated Care Clinical Academic Group in the South London and Maudsley NHS Trust where he is also a Consultant Psychiatrist and the head of the National Affective Disorders Tertiary Clinic.  

Professor Young’s research interests focus on the cause and treatments for severe psychiatric illnesses, particularly mood disorders like depression. He has received research grant funding from the UK Medical Research Council, the Wellcome Trust, and numerous other respected funding agencies worldwide. He has published over 400 peer-reviewed publications and a number of books about psychopharmacology and affective disorders. According to the 2014 Thomson Reuters Highly Cited Researcher list, Professor Young was recently ranked as one of the world's leading scientific minds in the field of Psychiatry and Psychology. 

Depression

Bipolar disorder

Major depressive episode

Anhedonia

ICD-10

DSM-5

Atypical depression

Immuno-metabolic depression

SSRI

Rapid cycling bipolar disorder

Tricyclic antidepressants

Monoamine oxidase inhibitors (MAOIs)

Dopamine receptor D2

Cognitive Remediation Therapy

Institute of Psychiatry, Psychology & Neuroscience

CBT

Ketamine

Esketamine: Ketamine nasal spray 

Bioavailability

Psilocybin: From Serendipity to Credibility?

COMPASS Pathways

★ Support this podcast ★

Professor Allan Young is a psychopharmacologist and the Director of the Centre for Affective Disorders in the Department of Psychological Medicine in the Institute of Psychiatry, Psychology and Neuroscience at King’s College London. Prof Young is the clinical academic lead in the Psychological Medicine and Integrated Care Clinical Academic Group in the South London and Maudsley NHS Trust where he is also a Consultant Psychiatrist and the head of the National Affective Disorders Tertiary Clinic.  

Professor Young’s research interests focus on the cause and treatments for severe psychiatric illnesses, particularly mood disorders like depression. He has received research grant funding from the UK Medical Research Council, the Wellcome Trust, and numerous other respected funding agencies worldwide. He has published over 400 peer-reviewed publications and a number of books about psychopharmacology and affective disorders. According to the 2014 Thomson Reuters Highly Cited Researcher list, Professor Young was recently ranked as one of the world's leading scientific minds in the field of Psychiatry and Psychology. 

Depression

Bipolar disorder

Major depressive episode

Anhedonia

ICD-10

DSM-5

Atypical depression

Immuno-metabolic depression

SSRI

Rapid cycling bipolar disorder

Tricyclic antidepressants

Monoamine oxidase inhibitors (MAOIs)

Dopamine receptor D2

Cognitive Remediation Therapy

Institute of Psychiatry, Psychology & Neuroscience

CBT

Ketamine

Esketamine: Ketamine nasal spray 

Bioavailability

Psilocybin: From Serendipity to Credibility?

COMPASS Pathways

★ Support this podcast ★

Professor Allan Young is a psychopharmacologist and the Director of the Centre for Affective Disorders in the Department of Psychological Medicine in the Institute of Psychiatry, Psychology and Neuroscience at King’s College London. Prof Young is the clinical academic lead in the Psychological Medicine and Integrated Care Clinical Academic Group in the South London and Maudsley NHS Trust where he is also a Consultant Psychiatrist and the head of the National Affective Disorders Tertiary Clinic.  

Professor Young’s research interests focus on the cause and treatments for severe psychiatric illnesses, particularly mood disorders like depression. He has received research grant funding from the UK Medical Research Council, the Wellcome Trust, and numerous other respected funding agencies worldwide. He has published over 400 peer-reviewed publications and a number of books about psychopharmacology and affective disorders. According to the 2014 Thomson Reuters Highly Cited Researcher list, Professor Young was recently ranked as one of the world's leading scientific minds in the field of Psychiatry and Psychology. 

Depression

Bipolar disorder

Major depressive episode

Anhedonia

ICD-10

DSM-5

Atypical depression

Immuno-metabolic depression

SSRI

Rapid cycling bipolar disorder

Tricyclic antidepressants

Monoamine oxidase inhibitors (MAOIs)

Dopamine receptor D2

Cognitive Remediation Therapy

Institute of Psychiatry, Psychology & Neuroscience

CBT

Ketamine

Esketamine: Ketamine nasal spray 

Bioavailability

Psilocybin: From Serendipity to Credibility?

COMPASS Pathways

★ Support this podcast ★

Professor Allan Young is a psychopharmacologist and the Director of the Centre for Affective Disorders in the Department of Psychological Medicine in the Institute of Psychiatry, Psychology and Neuroscience at King’s College London. Prof Young is the clinical academic lead in the Psychological Medicine and Integrated Care Clinical Academic Group in the South London and Maudsley NHS Trust where he is also a Consultant Psychiatrist and the head of the National Affective Disorders Tertiary Clinic.  

Professor Young’s research interests focus on the cause and treatments for severe psychiatric illnesses, particularly mood disorders like depression. He has received research grant funding from the UK Medical Research Council, the Wellcome Trust, and numerous other respected funding agencies worldwide. He has published over 400 peer-reviewed publications and a number of books about psychopharmacology and affective disorders. According to the 2014 Thomson Reuters Highly Cited Researcher list, Professor Young was recently ranked as one of the world's leading scientific minds in the field of Psychiatry and Psychology. 

Depression

Bipolar disorder

Major depressive episode

Anhedonia

ICD-10

DSM-5

Atypical depression

Immuno-metabolic depression

SSRI

Rapid cycling bipolar disorder

Tricyclic antidepressants

Monoamine oxidase inhibitors (MAOIs)

Dopamine receptor D2

Cognitive Remediation Therapy

Institute of Psychiatry, Psychology & Neuroscience

CBT

Ketamine

Esketamine: Ketamine nasal spray 

Bioavailability

Psilocybin: From Serendipity to Credibility?

COMPASS Pathways

★ Support this podcast ★